The William Dameshek Division of Hematology/Oncology at New England Medical Center (NEMC) is submitting this renewal application for T32 CA 09429 entitled """"""""Research Training in Oncology,"""""""" in order to continue its mission of training dedicated physicians and scientists for independent careers in oncology research. The program is based in the Division of Hematology/Oncology at New England Medical Center, the principal teaching hospital for Tufts University School of Medicine. It includes members of the division as well as scientists of the basic science faculty of Tufts Medical School, the Sackler School of Graduate Biomedical Sciences, the Division of Radiation Biology Research in the Department of Radiation Oncology, and the Cancer Genetics program. All are affiliated with the Cancer Center of New England Medical Center, which provides generous research support for its members. ? ? The Division of Hematology/Oncology is an important research training program for the United States and Canada. Former trainees now head major departments in academia and NCI funded cancer centers, major research laboratories, and large pharmaceutical divisions involved in oncology drug development. ? ? This training grant includes 19 research faculty who were selected on the basis of proven scientific achievement, mentoring skills, research program participation and the feedback and experience of postdoctoral fellows. Relevance of the member's research program to furthering the understanding of neoplasia was crucial. The selected faculty is highly accomplished and includes 8 Full Professors, 5 Associate Professors, and 6 Assistant Professors. Since the last competitive renewal, the training program has increased its focus on basic research involving breast cancer transformation and signal transduction. ? ? The several themes emerging in the construct of this grant include molecular and cellular events in breast cancer, signal transduction, and retroviral oncogenesis reflecting local strengths and collaborations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009429-22
Application #
6769325
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
1981-09-01
Project End
2008-06-30
Budget Start
2004-09-01
Budget End
2005-06-30
Support Year
22
Fiscal Year
2004
Total Cost
$224,579
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
079532263
City
Boston
State
MA
Country
United States
Zip Code
02111
Shah, Gunjan L; Winn, Aaron; Lin, Pei-Jung et al. (2016) Cost Implications of Comorbidity for Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma Using SEER-Medicare. Bone Marrow Res 2016:3645623
Buchsbaum, Rachel J; Oh, Sun Young (2016) Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go. Cancers (Basel) 8:
Xu, Kun; Tian, Xuejun; Oh, Sun Y et al. (2016) The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis. Breast Cancer Res 18:14
Winn, Aaron N; Shah, Gunjan L; Cohen, Joshua T et al. (2015) The real world effectiveness of hematopoietic transplant among elderly individuals with multiple myeloma. J Natl Cancer Inst 107:
Saret, Cayla J; Winn, Aaron N; Shah, Gunjan et al. (2015) Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses. Blood 125:1866-9
Shah, Gunjan L; Winn, Aaron N; Lin, Pei-Jung et al. (2015) Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results-Medicare Database. Biol Blood Marrow Transplant 21:1823-9
Shah, Gunjan L; Rosenberg, Aaron S; Jarboe, Jamie et al. (2014) Incidence and evaluation of incidental abnormal bone marrow signal on magnetic resonance imaging. ScientificWorldJournal 2014:380814
Shah, Gunjan; Yamin, Hanah; Smith, Hedy (2013) Mitomycin-C-Induced TTP/HUS Treated Successfully with Rituximab: Case Report and Review of the Literature. Case Rep Hematol 2013:130978
Kaimal, Rajani; Aljumaily, Raid; Tressel, Sarah L et al. (2013) Selective blockade of matrix metalloprotease-14 with a monoclonal antibody abrogates invasion, angiogenesis, and tumor growth in ovarian cancer. Cancer Res 73:2457-2467
Ahmed, Wesam; Van Etten, Richard A (2013) Signal transduction in the chronic leukemias: implications for targeted therapies. Curr Hematol Malig Rep 8:71-80

Showing the most recent 10 out of 34 publications